{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:42:00Z","timestamp":1789990920220,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.cyto.2017.05.008","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T19:15:19Z","timestamp":1496776519000},"page":"279-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7413-2039","authenticated-orcid":false,"given":"Gabriela","family":"Aguilo-Seara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrod","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda L.","family":"Kusner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2017.05.008_b0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/WCO.0b013e32833cc968","article-title":"Autoimmune mediated neuromuscular junction defects","volume":"23","author":"Farrugia","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.cyto.2017.05.008_b0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/WCO.0b013e328364d6cd","article-title":"Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation","volume":"26","author":"Le Panse","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.cyto.2017.05.008_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2015.02.009","article-title":"Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization","author":"Tuzun","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cyto.2017.05.008_b0020","first-page":"995","article-title":"The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat","volume":"139","author":"Meinl","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2017.05.008_b0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.06.011","article-title":"Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients","volume":"78","author":"Xie","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2017.05.008_b0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"Roche","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cyto.2017.05.008_b0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-alpha","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cyto.2017.05.008_b0040","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","article-title":"Autoreactive T Cells from patients with Myasthenia Gravis Are characterized by elevated IL-17, IFN-gamma, and GM-CSF and Diminished IL-10 production","volume":"196","author":"Cao","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0045","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/eji.201445064","article-title":"IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis","volume":"45","author":"Schaffert","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0050","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/mus.24057","article-title":"Targeting therapy to the neuromuscular junction: proof of concept","volume":"49","author":"Kusner","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cyto.2017.05.008_b0055","doi-asserted-by":"crossref","first-page":"e102231","DOI":"10.1371\/journal.pone.0102231","article-title":"Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study","volume":"9","author":"Kusner","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2017.05.008_b0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.cyto.2017.05.008_b0065","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/eji.200737973","article-title":"CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity","volume":"38","author":"Bai","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0070","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.coi.2012.10.003","article-title":"Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity","volume":"24","author":"Sweet","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0075","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.4049\/jimmunol.0901499","article-title":"Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17","volume":"183","author":"Blaho","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0080","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1189\/jlb.1VMR0216-096RR","article-title":"IL-17 superfamily cytokines modulate normal germinal center B cell migration","volume":"100","author":"Ferretti","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2017.05.008_b0085","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4049\/jimmunol.1300479","article-title":"IL-17RA is essential for optimal localization of follicular Th cells in the germinal center light zone to promote autoantibody-producing B cells","volume":"191","author":"Ding","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0090","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","article-title":"Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice Is associated with reduced germinal center formation and C3 production","volume":"169","author":"Deng","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0095","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2487::AID-IMMU2487>3.0.CO;2-Y","article-title":"IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease","volume":"28","author":"Moiola","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0100","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.4049\/jimmunol.178.11.7072","article-title":"C57BL\/6 mice genetically deficient in IL-12\/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells","volume":"178","author":"Wang","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0105","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.4049\/jimmunol.164.10.5236","article-title":"Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL\/6 mice","volume":"164","author":"Karachunski","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.186.3.385","article-title":"Interferon (IFN-) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice","volume":"186","author":"Balasa","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2017.05.008_b0115","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2017.05.008_b0120","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.4049\/jimmunol.179.12.8562","article-title":"Anti-C5 antibody treatment ameliorates weakness in experimentally acquired myasthenia gravis","volume":"179","author":"Zhou","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0125","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","article-title":"Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production","volume":"192","author":"Breitfeld","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2017.05.008_b0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.molimm.2013.01.006","article-title":"The Bcl6 target gene microRNA-21 promotes Th2 differentiation by a T cell intrinsic pathway","volume":"54","author":"Sawant","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cyto.2017.05.008_b0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/imm.12393","article-title":"The transcriptional repressor Bcl6 controls the stability of regulatory T cells by intrinsic and extrinsic pathways","volume":"145","author":"Sawant","year":"2015","journal-title":"Immunology"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617301291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617301291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T22:57:57Z","timestamp":1535756277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617301291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":27,"alternative-id":["S1043466617301291"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.05.008","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}